\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes Digital, Industry & SpaceThe CEF2 Digital programme will grant funds for the rapid deployment and take up of 5G for smart communities and innovative applications.
In healthcare, 5G-connected hospitals or ambulances can help monitor patients, make early diagnostics, and enable personalised medical advice and treatment.
In education, 5G in underserved areas will allow students to take part in classes from remote locations with virtual and augmented reality, allowing for increased interaction and making lessons more efficient and fun. The technology has the potential of spreading online learning, which has become more and more common during the pandemic.
The Commission launched a call as part of CEF Digital in January 2022. It will select projects that constitute examples of concrete 5G use cases and that have the potential of sparking incentive for future 5G-based application developments in different sectors.
The details of the new call topic are expected to appear within a week or so. You can already check some of the call topics of the first wave for inspiration.
More information will be given during the matchmaking event on Sep 20.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Cybersecurity
The European Cybersecurity Competence Centre (ECCC) has opened a call for tenders to set up a European testing infrastructure for post-quantum cryptography (PQC). Open to applicants across the European Economic Area, the contract is worth EUR 25 million and covers IT services including development and support. The submission deadline is 20 Februa... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
